๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
This double-blind study will evaluate the pharmacokinetics of a single dose...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-08
Trial ID
NCT01476124
Treatments Being Tested
The primary objective of this trial is to assess the efficacy of XP13512 ta...
Status
Completed
Location
Multiple Locations
Start Date
2006-03
Trial ID
NCT00298623
Treatments Being Tested
To demonstrate the superiority of ASP8825 over placebo and the dose respons...
Status
Completed
Location
Multiple Locations
Start Date
2007-09
Trial ID
NCT00530530
Gabapentin enacarbil (GEn; GSK1838262; HORIZANT), at a dose of 600 mg/day, ...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-06
Trial ID
NCT01668667
Treatments Being Tested
The primary objective of this trial is to assess the efficacy of XP13512 ta...
Status
Completed
Location
Multiple Locations
Start Date
2006-08
Trial ID
NCT00365352
Treatments Being Tested
Purpose of the study is to evaluate dose response relationship, efficacy, s...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-08
Trial ID
NCT00742209
Treatments Being Tested
The objective of this study is to evaluate the efficacy and safety of ASP88...
Status
Completed
Location
Multiple Locations
Start Date
2007-12
Trial ID
NCT02658188
Treatments Being Tested
This study was a multi center, randomized, double blind, active and placebo...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-04
Trial ID
NCT01332318
Treatments Being Tested
The primary objective of this trial is to assess the long-term safety and e...
Status
Completed
Location
Multiple Locations
Start Date
2006-06
Trial ID
NCT00333359
Treatments Being Tested
The objective of this study is to evaluate the pharmacokinetics and safety ...
Status
Completed
Location
Multiple Locations
Start Date
2008-02
Trial ID
NCT02629224
Treatments Being Tested